Last update:

Oncology & Cancer news

Oncology & Cancer

Switch of breast tumors to HER2-low in recurrence may provide greater therapeutic options

The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently ...

Medical research

Turning a pancreatic cancer cell's addiction into a death sentence

Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.

Oncology & Cancer

Breaching the blood-brain barrier to deliver precious payloads

RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and ...

Oncology & Cancer

Possible origin of neuroblastoma in the adrenal glands discovered

Neuroblastoma is a childhood cancer, most commonly affecting children aged between two to three and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's ...

Oncology & Cancer

Tumors hide from the immune system with help from this protein

Cancer drugs called immune checkpoint inhibitors boost the immune system's ability to find and destroy tumor cells, but they don't work for most patients. Researchers at the Broad Institute of MIT and Harvard, Massachusetts ...

Medical research

Research breakthrough in the fight against cancer

A team of researchers at the Center for Bioactive Delivery at the University of Massachusetts Amherst's Institute for Applied Life Sciences has engineered a nanoparticle that has the potential to revolutionize disease treatment, ...

Oncology & Cancer

Mitochondrial DNA in cancer: Small genome, big impact

Mitochondria are in vogue, with devotees ranging from exercise physiologists and sports scientists to molecular biologists and clinicians all coalescing around these unusual organelles.

Oncology & Cancer

Universal multigene panel test in CRC IDs heritable mutations

(HealthDay)—One in six patients with colorectal cancer (CRC) has an inherited cancer-related gene mutation, and 60 percent of these cases would not have been detected using guideline-based testing, according to a study ...